Abstract

Lamotrigine is a second-generation anticonvulsant approved for the treatment of epilepsy. Like other antiepileptics, lamotrigine is also used off-label in bipolar disorders as a mood stabiliser. We describe the case of a patient suffering from bipolar disorder type 2 who developed ocular toxicity following the use of lamotrigine in the management of his mental illness. The vast majority of these visual side effects are non-serious, rare, of mild to moderate intensity. And they appear to be reversible once treatment is stopped.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.